Biocon Limited — Board Meeting, 30-01-2025: Outcome of Board Meeting

The Board of Biocon Limited has approved the unaudited financial results for the quarter and nine months ended December 31, 2024, reflecting a total income of ₹632.70 crore, with a revenue from operations of ₹582.80 crore. The profit for the period stands at ₹584.00 crore. The Board has also amended the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. This meeting's decisions are set to impact strategic operations significantly, particularly through ongoing efforts to enhance financial stability and shareholder value.